“Low-Dose” Aprotinin Modifies Hemostasis but Not Proinflammatory Cytokine Release

Kirklin, 1983, Complement and damaging effects of cardiopulmonary bypass, J Thorac Cardiovasc Surg, 86, 845, 10.1016/S0022-5223(19)39061-0

Butler, 1993, Inflammatory response to cardiopulmonary bypass, Ann Thorac Surg, 55, 552, 10.1016/0003-4975(93)91048-R

Steinberg, 1993, Cytokine and complement levels in patients undergoing cardiopulmonary bypass, J Thorac Cardiovasc Surg, 106, 1008, 10.1016/S0022-5223(19)33971-6

Finn, 1993, Interleukin-8 release and neutrophil degranulation after paediatric cardiopulmonary bypass, J Thorac Cardiovasc Surg, 105, 234, 10.1016/S0022-5223(19)33806-1

Hennein, 1994, Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization, J Thorac Cardiovasc Surg, 108, 626, 10.1016/S0022-5223(94)70286-1

Kalfin, 1993, Induction of interleukin-8 expression during cardiopulmonary bypass, Circulation, 88, 401

Engelman, 1995, Influence of steroids on complement and cytokine generation after cardiopulmonary bypass, Ann Thorac Surg, 60, 801, 10.1016/0003-4975(95)00211-3

Marewitz, 1993, Regulation of acute phase response after cardiopulmonary bypass by immunomodulation, Ann Thorac Surg, 55, 389, 10.1016/0003-4975(93)91007-A

Bando, 1990, Leukocyte depletion ameliorates free radical mediated lung injury after cardiopulmonary bypass, J Thorac Cardiovasc Surg, 99, 873, 10.1016/S0022-5223(19)36903-X

Videm, 1992, Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operation, J Thorac Cardiovasc Surg, 103, 806, 10.1016/S0022-5223(19)34966-9

Gu, 1993, Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass, Ann Thorac Surg, 55, 917, 10.1016/0003-4975(93)90117-Z

Steinberg, 1995, Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass, Ann Thorac Surg, 60, 525, 10.1016/0003-4975(95)00482-Z

Van Oeveren, 1987, Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass, Ann Thorac Surg, 44, 640, 10.1016/S0003-4975(10)62153-4

Van Oeveren, 1990, Aprotinin protects platelets against the initial effect of cardiopulmonary bypass, J Thorac Cardiovasc Surg, 99, 788, 10.1016/S0022-5223(19)36893-X

Lavee, 1993, Platelet protection by low-dose aprotinin in cardiopulmonary bypass, Ann Thorac Surg, 55, 114, 10.1016/0003-4975(93)90484-Y

Bidstrup, 1993, Aprotinin therapy in cardiac operations, Ann Thorac Surg, 55, 971, 10.1016/0003-4975(93)90128-5

Wachtfogel, 1993, Aprotinin inhibits the contact, neutrophil, and platelet activation system during simulated extracorporeal perfusion, J Thorac Cardiovasc Surg, 106, 1, 10.1016/S0022-5223(19)33735-3

Wachtfogel, 1995, Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation, Am J Physiol, 268, H1353

Westaby, 1993, Aprotinin in perspective, Ann Thorac Surg, 55, 1033, 10.1016/0003-4975(93)90149-C

Jansen, 1991, Inhibition by dexamethasone of the reperfusion phenomena in cardiopulmonary bypass, J Thorac Cardiovasc Surg, 102, 515, 10.1016/S0022-5223(20)31421-5

Seghaye, 1996, Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children, Ann Thorac Surg, 61, 1205, 10.1016/0003-4975(96)00013-6

Smith, 1991, Interleukin-8 induces neutrophil transendothelial migration, Immunology, 72, 65

Endo, 1992, Polymorphonuclear leukocyte elastase and plasma interleukin 8 levels in patients with ARDS, J Jpn Assoc Acute Med, 3, 92

Blauhut, 1991, Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass, J Thorac Cardiovasc Surg, 101, 958, 10.1016/S0022-5223(19)36611-5

Cosgrove, 1992, Aprotinin therapy for reoperative myocardial revascularization, Ann Thorac Surg, 54, 1031, 10.1016/0003-4975(92)90066-D